Literature DB >> 22837324

Modeling uncertainty in single-copy assays for HIV.

Rutao Luo1, Michael J Piovoso, Ryan Zurakowski.   

Abstract

We present a simple computational model of measurement accuracy for single-copy sensitivity assays (SCA) of HIV RNA that was developed from first principles. The model shows that the SCA is significantly right-skewed. Measured virus concentrations of 1 and 10 virions/ml had overlapping 95% confidence intervals and were statistically indistinguishable.

Entities:  

Mesh:

Year:  2012        PMID: 22837324      PMCID: PMC3457444          DOI: 10.1128/JCM.01254-12

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  6 in total

1.  A Bayesian approach to parameter estimation in HIV dynamical models.

Authors:  H Putter; S H Heisterkamp; J M A Lange; F de Wolf
Journal:  Stat Med       Date:  2002-08-15       Impact factor: 2.373

Review 2.  New tools for quantifying HIV-1 reservoirs: plasma RNA single copy assays and beyond.

Authors:  Benedict B Hilldorfer; Anthony R Cillo; Guillaume J Besson; Margaret Anne Bedison; John W Mellors
Journal:  Curr HIV/AIDS Rep       Date:  2012-03       Impact factor: 5.071

3.  Multicenter performance evaluation of a new TaqMan PCR assay for monitoring human immunodeficiency virus RNA load.

Authors:  L Perrin; J M Pawlotsky; M Bouvier-Alias; C Sarrazin; S Zeuzem; G Colucci
Journal:  J Clin Microbiol       Date:  2006-09-27       Impact factor: 5.948

4.  New real-time reverse transcriptase-initiated PCR assay with single-copy sensitivity for human immunodeficiency virus type 1 RNA in plasma.

Authors:  Sarah Palmer; Ann P Wiegand; Frank Maldarelli; Holly Bazmi; JoAnn M Mican; Michael Polis; Robin L Dewar; Angeline Planta; Shuying Liu; Julia A Metcalf; John W Mellors; John M Coffin
Journal:  J Clin Microbiol       Date:  2003-10       Impact factor: 5.948

5.  HIV model parameter estimates from interruption trial data including drug efficacy and reservoir dynamics.

Authors:  Rutao Luo; Michael J Piovoso; Javier Martinez-Picado; Ryan Zurakowski
Journal:  PLoS One       Date:  2012-07-16       Impact factor: 3.240

6.  Quantification of mRNA in single cells and modelling of RT-qPCR induced noise.

Authors:  Martin Bengtsson; Martin Hemberg; Patrik Rorsman; Anders Ståhlberg
Journal:  BMC Mol Biol       Date:  2008-07-17       Impact factor: 2.946

  6 in total
  6 in total

1.  Implications of Measurement Assay Type in Design of HIV Experiments.

Authors:  LaMont Cannon; Aditya Jagarapu; Cesar A Vargas-Garcia; Michael J Piovoso; Ryan Zurakowski
Journal:  Proc IEEE Conf Decis Control       Date:  2018-01-23

2.  Long-term antiretroviral treatment initiated at primary HIV-1 infection affects the size, composition, and decay kinetics of the reservoir of HIV-1-infected CD4 T cells.

Authors:  Maria J Buzon; Enrique Martin-Gayo; Florencia Pereyra; Zhengyu Ouyang; Hong Sun; Jonathan Z Li; Michael Piovoso; Amy Shaw; Judith Dalmau; Nadine Zangger; Javier Martinez-Picado; Ryan Zurakowski; Xu G Yu; Amalio Telenti; Bruce D Walker; Eric S Rosenberg; Mathias Lichterfeld
Journal:  J Virol       Date:  2014-06-25       Impact factor: 5.103

3.  Experiment Design for Early Molecular Events in HIV Infection.

Authors:  Aditya Jagarapu; LaMont Cannon; Ryan Zurakowski
Journal:  Proc Am Control Conf       Date:  2017-07-03

4.  Modelling HIV-1 2-LTR dynamics following raltegravir intensification.

Authors:  Rutao Luo; E Fabian Cardozo; Michael J Piovoso; Hulin Wu; Maria J Buzon; Javier Martinez-Picado; Ryan Zurakowski
Journal:  J R Soc Interface       Date:  2013-05-08       Impact factor: 4.118

5.  HIV 2-LTR experiment design optimization.

Authors:  LaMont Cannon; Cesar A Vargas-Garcia; Aditya Jagarapu; Michael J Piovoso; Ryan Zurakowski
Journal:  PLoS One       Date:  2018-11-08       Impact factor: 3.240

6.  Modeling HIV-1 Within-Host Dynamics After Passive Infusion of the Broadly Neutralizing Antibody VRC01.

Authors:  E Fabian Cardozo-Ojeda; Alan S Perelson
Journal:  Front Immunol       Date:  2021-08-31       Impact factor: 7.561

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.